Evidence map›Paper›PMID 30746898›Full record

Observational studyJournal of the International AIDS Society2019

ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa.

Jessica E Haberer, Bosco M Bwana, Catherine Orrell, Stephen Asiimwe, Gideon Amanyire, Nicholas Musinguzi, Mark J Siedner, Lynn T Matthews, Alexander C Tsai, Ingrid T Katz and 8 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Jessica E HabererMassachusetts General Hospital Center for Global Health, Boston, MA, USA.ORCID 0000-0001-5845-3190
Bosco M BwanaMbarara University of Science and Technology, Mbarara, Uganda.
Catherine OrrellDesmond Tutu HIV Foundation, Cape Town, South Africa.
Stephen AsiimweGlobal Health Collaborative, Mbarara, Uganda.
Gideon AmanyireGlobal Health Collaborative, Mbarara, Uganda.
Nicholas MusinguziGlobal Health Collaborative, Mbarara, Uganda.
Mark J SiednerMassachusetts General Hospital Center for Global Health, Boston, MA, USA.
Lynn T MatthewsMassachusetts General Hospital Center for Global Health, Boston, MA, USA.
Alexander C TsaiMassachusetts General Hospital Center for Global Health, Boston, MA, USA.
Ingrid T KatzHarvard Medical School, Boston, MA, USA.
Kathleen BellMassachusetts General Hospital Center for Global Health, Boston, MA, USA.
Annet KembabaziGlobal Health Collaborative, Mbarara, Uganda.
Stephen MugishaGlobal Health Collaborative, Mbarara, Uganda.
Victoria KibirigeGlobal Health Collaborative, Mbarara, Uganda.
Anna CrossDesmond Tutu HIV Foundation, Cape Town, South Africa.
Nicola KellyDesmond Tutu HIV Foundation, Cape Town, South Africa.
Bethany Hedt-GauthierMassachusetts General Hospital Center for Global Health, Boston, MA, USA.
David R BangsbergOregon Health & Science University-Portland State University School of Public Health, Portland, OR, USA.
World Health Organization - Uganda · UGHarvard University · USDesmond Tutu HIV Foundation · ZABrigham and Women's Hospital · USMassachusetts General Hospital · USMbarara University of Science and Technology · UGPortland State University · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
NIAID NIH HHS P30 AI027763
6 · The paper itself

Abstract

introductionThe success of universal antiretroviral therapy (ART) access and aspirations for an AIDS-free generation depend on high adherence in individuals initiating ART during early-stage HIV infection; however, adherence may be difficult in the absence of illness and associated support.

methodsFrom March 2015 to October 2017, we prospectively observed three groups initiating ART in routine care in Uganda and South Africa: men and non-pregnant women with early-stage HIV infection (CD4 > 350 cells/μL), pregnant women with early-stage HIV infection and men and non-pregnant women with late-stage HIV infection (CD4 < 200 cells/μL). Socio-behavioural questionnaires were administered and viral loads were performed at 0, 6 and 12 months. Adherence was monitored electronically.

resultsAdherence data were available for 869 participants: 322 (37%) early/non-pregnant, 199 (23%) early/pregnant and 348 (40%) late/non-pregnant participants. In Uganda, median adherence was 89% (interquartile range 74 to 96) and viral suppression was 90% at 12 months; neither differed among groups (p > 0.72). In South Africa, median adherence was higher in early/non-pregnant versus early/pregnant or late/non-pregnant participants (76%, 37%, 52%; p < 0.001), with similar trends in viral suppression (86%, 51%, 79%; p < 0.001). Among early/non-pregnant individuals in Uganda, adherence was higher with increasing age and lower with structural barriers; whereas in South Africa, adherence was higher with regular income, higher perceived stigma and use of other medications, but lower with maladaptive coping and cigarette smoking. DISCUSSION: ART adherence among non-pregnant individuals with early-stage infection is as high or higher than with late-stage initiation, supporting universal access to ART. Challenges remain for some pregnant women and individuals with late-stage infection in South Africa and highlight the need for differentiated care delivery.

Indexed as

Medication AdherenceAdultAnti-HIV AgentsAsymptomatic DiseasesFemaleHIV-1HIV InfectionsHumansMalePregnancyPregnant PeopleSouth AfricaUgandaViral LoadYoung AdultAnti-HIV Agentsadherenceantiretroviral therapyHIVstage of diseasesub-Saharan Africa

Identifiers

PMID30746898
PMCPMC6371013
OpenAlexW2913170605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.